Not checkedNot checked for notices yet.
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis
Ivo S. Muskens, Shaobo Li, Thomas Jackson and 18 more
Nature Communications · 2021
doi:10.1038/s41467-021-21064-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Down syndrome has a high co-morbidity with immune and hematopoietic disorders. Here, the authors perform an epigenome-wide association study in newborns with and without Down syndrome to find differential methylation across the genome, including in hematopoietic regulators RUNX1 and FLI1.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.